Patent ID: 7977378
Filing Date: 2011-07-12
Classification: A61K

Abstract:
1. A method for enhancing weight loss in a human, which comprises; a. administering to a human seeking to lose weight at least one weight loss enhancing nutrient of Cycle I selected from the group consisting of epigallocatechin gallate, chlorogenic acid, caffeine, synephrine, evodiamine and naringenin, and the enantiomers and pharmaceutically acceptable salts thereof for a period of time insufficient to develop tolerance to the administration; and b. then replacing said at least one weight loss enhancing nutrient of Cycle I with an appropriate amount of at least one weight loss enhancing nutrient of Cycle II that maintains the adenylate cyclase receptor selected from the group consisting of one or more of cyanocobalamin, methylcobalamin, S-adenosylcobalamin and cyclic adenosine monophosphate and administering said weight loss enhancing nutrient that maintains the adenylate cyclase receptor for a period of time insufficient to develop tolerance to the administration; and c. repeating steps a. and b. over and over; whereby weight loss is promoted, for as long as the weight loss regimen continues.